{"id":"https://openalex.org/W3210022586","doi":null,"title":"Identifying And Targeting Mechanisms Of Immune Cell Activation In Imcd-Tafro","display_name":"Identifying And Targeting Mechanisms Of Immune Cell Activation In Imcd-Tafro","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3210022586","mag":"3210022586"},"language":"en","primary_location":{"id":"pmh:oai:repository.upenn.edu:20.500.14332/30759","doi":null,"is_oa":false,"landing_page_url":"https://repository.upenn.edu/handle/20.500.14332/30759","pdf_url":null,"source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"published","raw_type":"Dissertation/Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022412340","display_name":"Ruth-Anne Langan Pai","orcid":"https://orcid.org/0000-0001-9413-7611","observed_orcids":["https://orcid.org/0000-0001-9413-7611"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ruth-Anne Langan Pai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9413-7611","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5022412340"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11576","display_name":"IgG4-Related and Inflammatory Diseases","score":0.17219999432563782,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.05530000105500221,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-multicentric-castleman-disease","display_name":"idiopathic multicentric Castleman disease","score":0.9909999966621399},{"id":"https://openalex.org/keywords/mtorc1-signaling","display_name":"mTORC1 signaling","score":0.9599999785423279},{"id":"https://openalex.org/keywords/type-i-interferon-response","display_name":"type I interferon response","score":0.781000018119812},{"id":"https://openalex.org/keywords/jak-signaling","display_name":"JAK signaling","score":0.9559999704360962},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/monocyte-activation","display_name":"monocyte activation","score":0.6959999799728394},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/mtor-inhibitor-therapy","display_name":"mTOR inhibitor therapy","score":0.703000009059906},{"id":"https://openalex.org/keywords/disease-flares","display_name":"disease flares","score":0.6489999890327454},{"id":"https://openalex.org/keywords/knock-in-mice","display_name":"knock-in mice","score":0.6299999952316284},{"id":"https://openalex.org/keywords/reticulin-fibrosis","display_name":"reticulin fibrosis","score":0.699999988079071},{"id":"https://openalex.org/keywords/anasarca","display_name":"anasarca","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5115824341773987},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4620487093925476},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4313217103481293},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28198492527008057},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25595980882644653}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:repository.upenn.edu:20.500.14332/30759","doi":null,"is_oa":false,"landing_page_url":"https://repository.upenn.edu/handle/20.500.14332/30759","pdf_url":null,"source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"published","raw_type":"Dissertation/Thesis"},{"id":"pmh:oai:repository.upenn.edu:edissertations-5494","doi":null,"is_oa":false,"landing_page_url":"https://repository.upenn.edu/edissertations/3708","pdf_url":null,"source":{"id":"https://openalex.org/S4306402083","display_name":"ScholarlyCommons (University of Pennsylvania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79576946","host_organization_name":"University of Pennsylvania","host_organization_lineage":["https://openalex.org/I79576946"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Publicly Accessible Penn Dissertations","raw_type":"text"},{"id":"mag:3210022586","doi":null,"is_oa":false,"landing_page_url":"https://repository.upenn.edu/edissertations/3708/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3023502777","https://openalex.org/W2983414746","https://openalex.org/W4200453144","https://openalex.org/W2973187900","https://openalex.org/W4403800066","https://openalex.org/W2966078284","https://openalex.org/W2324844633","https://openalex.org/W2900754434","https://openalex.org/W2104949735","https://openalex.org/W7203599404"],"abstract_inverted_index":{"Idiopathic":[0],"multicentric":[1],"Castleman":[2],"disease":[3,15,51],"(iMCD)":[4],"is":[5,47,207],"a":[6,54,74,162,226,328],"rare,":[7],"deadly":[8],"hematologic":[9],"illness":[10],"of":[11,17,30,38,57,229,270,282,309,318,336],"unknown":[12],"etiology":[13],"involving":[14],"flares":[16,52],"systemic":[18],"inflammation":[19],"and":[20,41,68,82,94,106,113,122,127,150,152,170,186,212,233,258,260,297,304,321,324,340,343],"multiple":[21],"organ":[22],"system":[23],"dysfunction.":[24],"This":[25,201],"work":[26],"shows":[27],"increased":[28,136,180,202,280,337],"activation":[29,67,121,182,206,232],"the":[31,166,268,294],"mTORC1":[32,66,338,342],"signaling":[33,154,211],"pathway":[34],"in":[35,49,53,84,124,174,183,191,197,224,252,349],"lymph":[36],"nodes":[37],"iMCD":[39,85],"patients":[40,86,190],"demonstrates":[42],"that":[43,222],"an":[44,240],"mTOR":[45,153,171,181,205],"inhibitor":[46],"effective":[48],"preventing":[50],"small":[55],"cohort":[56],"patients.":[58],"We":[59,72,97,246],"next":[60],"ask":[61],"what":[62],"upstream":[63],"mechanisms":[64,83,299],"drive":[65],"downstream":[69],"clinical":[70],"features.":[71],"develop":[73],"targeted":[75],"approach":[76],"to":[77,194,199,239,244],"identify":[78,247,341],"candidate":[79],"cellular":[80,112],"drivers":[81],"with":[87,135,216,286],"thrombocytopenia,":[88],"anasarca,":[89],"fever,":[90],"reticulin":[91],"fibrosis/renal":[92],"dysfunction,":[93],"organomegaly":[95],"(iMCD-TAFRO).":[96],"leverage":[98],"paired":[99],"iMCD-TAFRO":[100,132,189,254,310],"PBMC":[101],"samples":[102],"collected":[103],"during":[104,131],"flare":[105],"remission":[107],"(n":[108],"=":[109],"10)":[110],"for":[111,331],"transcriptomic":[114],"characterization.":[115],"These":[116],"studies":[117],"highlight":[118],"T":[119,146,184,230,322],"cell":[120,126,231,235,295,323],"alterations":[123],"NK":[125,148],"monocyte":[128,325],"subset":[129],"frequencies":[130],"flare,":[133],"associated":[134],"Type":[137],"I":[138],"Interferon":[139],"(IFN-I)":[140],"response":[141,168,198,243],"gene":[142,155,172],"signatures":[143,156],"across":[144],"CD8+":[145],"cells,":[147,149],"monocytes":[151,176,187],"within":[157],"monocytes.":[158],"Moreover,":[159],"we":[160],"find":[161],"positive":[163],"correlation":[164],"between":[165],"IFN-I":[167,203,332],"genes":[169],"signature":[173],"classical":[175],"as":[177,179,333,345],"well":[178],"cells":[185],"from":[188],"remission,":[192],"compared":[193],"healthy":[195],"donors,":[196],"IFN\u03b2.":[200],"mediated":[204],"dependent":[208],"on":[209],"JAK":[210,217,344],"may":[213,237,292],"be":[214],"abrogated":[215],"inhibition.":[218],"Further":[219,290],"data":[220,314],"demonstrate":[221,327],"mutations":[223,251,320],"CABIN1,":[225],"negative":[227],"regulator":[228],"myeloid":[234],"differentiation,":[236],"lead":[238],"aberrant":[241],"immune":[242,298],"infection.":[245],"compound":[248],"heterozygous":[249],"CABIN1":[250,319],"our":[253,307],"index":[255],"case":[256],"patient":[257],"generate":[259],"characterize":[261],"knock-in":[262,272],"mice":[263,273],"containing":[264],"these":[265,271,313],"mutations.":[266],"While":[267],"immunophenotype":[269],"appear":[274],"normal":[275],"at":[276],"baseline,":[277],"they":[278],"display":[279],"rates":[281],"mortality":[283,302],"upon":[284],"infection":[285],"LCMV":[287],"Clone":[288],"13.":[289],"study":[291],"reveal":[293],"types":[296],"driving":[300],"this":[301],"phenotype":[303],"also":[305],"further":[306,316],"understanding":[308],"pathogenesis.":[311],"Altogether,":[312],"support":[315],"investigation":[317],"activation,":[326,339],"novel":[329],"role":[330],"mechanistic":[334],"driver":[335],"potential":[346],"therapeutic":[347],"targets":[348],"iMCD-TAFRO.":[350]},"counts_by_year":[],"updated_date":"2026-09-04T10:56:28.161419","created_date":"2021-11-08T00:00:00"}